XML 180 R71.htm IDEA: XBRL DOCUMENT v3.25.0.1
WARRANTS (Details Narrative) - USD ($)
4 Months Ended 12 Months Ended
Apr. 27, 2023
Feb. 13, 2023
Aug. 29, 2022
Aug. 15, 2022
Jul. 28, 2022
Jun. 26, 2022
Apr. 02, 2022
Apr. 02, 2022
Mar. 24, 2022
Feb. 01, 2022
May 13, 2021
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Share Price                           $ 20.09
Stock Issued During Period, Shares, New Issues     429 228,572         1,286   155,845 691,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                           0.00%
Share-Based Payment Arrangement, Expense                         $ 540,805  
Share-Based Payment Arrangement, Noncash Expense                         23,700 $ 84,171
Minimum [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate [1]                           3.46%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate [2]                           55.37%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term [3]                           5 years 3 months 21 days
Maximum [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate [1]                           3.48%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate [2]                           64.89%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term [3]                           6 years 3 months 21 days
Common Stock [Member]                            
Stock Issued During Period, Shares, New Issues 2,143 3,572                       228,572
Share-Based Payment Arrangement, Expense                         $ 47,680  
Letter Agreement [Member]                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights         4,423                  
Share-Based Payment Arrangement, Expense         $ 30,600                  
Letter Agreement [Member] | February 2022 Warrant [Member]                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                   11,058        
Share Price                   $ 0.35        
Stock Issued During Period, Shares, New Issues                   2,212        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate                   1.35%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate                   52.14%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                   0.00%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term                   9 months        
Debt Instrument, Fair Value Disclosure                   $ 332,859        
Share-Based Payment Arrangement, Noncash Expense                           $ 138,692
Investor Relations Agreement [Member]                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           5,715 8,574 8,574            
Stock Issued During Period, Shares, New Issues           1,715                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate             0.00%              
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum             1.72%              
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum             2.44%              
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum             52.14%              
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum             63.36%              
Fair Value Adjustment of Warrants             $ 40,350              
Investor Relations Agreement [Member] | Minimum [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term             1 year              
Investor Relations Agreement [Member] | Maximum [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term             2 years              
Investor Relations Agreement [Member] | Vest After12 Months [Member]                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           2,858 2,858 2,858            
Proceeds from Warrant Exercises               $ 56.00            
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 42.00                
Investor Relations Agreement [Member] | Vest Upon Laps of 18 Months [Member]                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             2,858 2,858            
Class of Warrant or Right, Exercise Price of Warrants or Rights             $ 66.50 $ 66.50            
Investor Relations Agreement [Member] | Vest After 24 Months [Member]                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             2,858 2,858            
Class of Warrant or Right, Exercise Price of Warrants or Rights             $ 77.00 $ 77.00            
Investor Relations Agreement [Member] | Vest After 6 Months [Member]                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           2,858                
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 31.50                
Investor Relations Agreement [Member] | Common Stock [Member]                            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           5,716                
Investor Relations Agreement [Member] | Warrant [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate           0.00%                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum           2.52%                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum           2.79%                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum           52.12%                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum           56.48%                
Fair Value Adjustment of Warrants           $ 7,009                
Investor Relations Agreement [Member] | Warrant [Member] | Minimum [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term           6 months                
Investor Relations Agreement [Member] | Warrant [Member] | Maximum [Member]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term           1 year                
[1] The risk-free interest rate represented the risk-free rate of $
[2] Due to the low trading volume of the Company’s common stock and lack of historical information, the expected volatility was based on the historical volatility of the share price of other public companies that operate in the same industry sector as the Company (agricultural chemical industry).
[3] Due to the fact that the Company does not have sufficient historical exercise data, the expected term was determined based on the “simplified method”.